Drug intelligence / Profile preview

pheniramine

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral, Topical, Ophthalmic, Intravenous, Intramuscular
01

Overview

Pheniramine is a first-generation antihistamine in the alkylamine class used to treat allergic conditions such as allergic rhinitis (hay fever), urticaria (hives), pruritus (itching), and conjunctivitis. It acts primarily as an antagonist and inverse agonist at the histamine H1 receptor, blocking the effects of histamine released during allergic reactions. This reduces symptoms like itching, redness, swelling (edema), sneezing, and runny nose. Pheniramine also has anticholinergic properties that contribute to its sedative effects. It is available in oral formulations as well as topical preparations for ophthalmic use and is often found in combination with other drugs for cold or allergy relief[1][2][4][6].

Brand names
Naphcon AOpcon-AVisine-AAvil
Other names
pheniramine
02

Targets

HRH4 (Histamine H4 receptor)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on pheniramine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pheniramine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call